Dishman Carbogen Amcis Limited Financial Ratios
DCAL · Healthcare · Current price ₹150
P/E ratio
24.1x
P/B ratio
0.4x
ROE
1.5%
ROCE
2.9%
Debt / Equity
0.46
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 24.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 1.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 2.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.46 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Dishman Carbogen Amcis Limited's latest numbers.
Dishman Carbogen Amcis Limited profitability
Dishman Carbogen Amcis Limited generates a return on equity of 1.5% and a return on capital employed of 2.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.46 and a P/E of 24.1x, Dishman Carbogen Amcis Limited is conservatively financed. Our overall business-quality score for the company is 3.8 / 10.
Understand the ratios
More on Dishman Carbogen Amcis Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.